Brief: Evelo Biosciences Completes Enrollment In Phase 1B Clinical Trial Cohort Evaluating EDP1815 In Atopic Dermatitis
14/10/2020 12:15
Oct 14 (Reuters) - Evelo Biosciences Inc EVLO.O :
* EVELO BIOSCIENCES COMPLETES ENROLLMENT IN PHASE 1B
CLINICAL
TRIAL COHORT EVALUATING EDP1815 IN ATOPIC DERMATITIS
* EVELO BIOSCIENCES INC - LOOK FORWARD TO ANNOUNCING DATA
FOR
PHASE1B TRIAL OF EPI815 EARLY NEXT YEAR
Source text for Eikon: ID:nGNX5MnPNh
Further company coverage: EVLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evelo Biosciences
See all newsU.S. RESEARCH ROUNDUP- Evelo Biosciences, Nkarta, O'Reilly Automotive
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI